Insomnia Disorder: Clinical Trials

69 trials for Insomnia Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

38 completed, 12 recruiting, 9 unknown, 6 not yet recruiting. 37 Not applicable, 13 Phase 3, 12 Phase 2, 4 Phase 4, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable37Completed 17, Recruiting 9, Unknown 5, Not yet recruiting 3, Active not recruiting 2, Terminated 1
Phase 313Completed 8, Not yet recruiting 2, Unknown 2, Recruiting 1
Phase 212Completed 9, Unknown 3
Phase 44Recruiting 2, Completed 1, Not yet recruiting 1
Phase 13Completed 2, Unknown 1

Follow Insomnia Disorder: new trials by email Literature Review of Insomnia Disorder trials Research Report on Insomnia Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sleep MAPP in the Polytrauma/TBI System of Care
Sleep MAPP Care Pathway - Insomnia Disorder, Mild Traumatic Brain Injury
Not applicableNot yet recruitingVA Office of Research and Development9002027-01-012026-10-21
Rumination-Tailored Guided Internet-Based CBT-I for University Students
Guided Internet-Based Cognitive Behavioral Therapy for Insomnia (iCBT-I), Rumination-Tailored Rule-Based Personalized Feedback - Insomnia, Insomnia Disorder
Not applicableActive not recruitingShahid Beheshti University of Medical Sciences702026-07-042026-07-14
A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder
HS-10506 - Insomnia Disorder
Phase 3Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.6002026-06-122026-06-30
Does Style Matter: Comparison of Moderate- to Low-intensity Styles of Yoga
Vinyasa yoga, Gentle yoga, Non-active control - Insomnia, Health Adult Subjects
Not applicableRecruitingCaitlin Cheruka422026-06-012026-08-13
A Study of HS-10506 in Chinese Patients With Insomnia Disorder
HS-10506, Placebo - Insomnia Disorder
Phase 3Not yet recruitingJiangsu Hansoh Pharmaceutical Co., Ltd.7322026-05-292026-05-14
Inulin-Spirulina Co-intervention for Insomnia Disorder
Inulin, Spirulina, Maltodextrin - Insomnia Disorder, Sleep Initiation and Maintenance Disorders
Not applicableNot yet recruitingFirst Affiliated Hospital of Zhejiang University1802026-05-012026-05-19
A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia
Sleep Hygiene Education, Melatonin IR, 3 mg, Melatonin IR, 5 mg - Insomnia, Insomnia Disorder
Phase 4RecruitingUniversity of Pennsylvania12002026-05-012026-09-16
Auricular Acupuncture Therapy Administered by Village Doctors Improves Sleep Quality in Elderly Patients With Comorbid Diabetes Mellitus and Hypertension
Auricular Acupuncture Therapy, Sham Auricular Acupuncture Group - Insomnia Disorder, Diabetes
Not applicableRecruitingJiangsu Taizhou People's Hospital3202026-04-222026-06-29
Internet-Based Cognitive Behavioral Therapy for Insomnia in Persian-Speaking Adults
Omid Internet-Based CBT-I Program - Insomnia Disorder, Chronic Insomnia
Not applicableCompletedRasool Hamidi Choolabi302026-02-212026-08-19
Compound Ciwujia Granules in the Treatment of Insomnia
Compound Ciwujia Granules group, Estazolam, Compound Ciwujia Granules and estazolam - Insomnia Disorder
Phase 4Not yet recruitingHui Zhu12002026-01-012025-12-29
Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2
Cognitive Behavioral Therapy for Insomnia (CBT-I), Passive Body Heating (PBH) - Insomnia Disorder
Not applicableRecruitingUniversity of California, San Francisco402025-09-292026-04-24
Virtual Reality Relaxation for Insomnia
Virtual reality relaxation intervention - Insomnia Disorder
Not applicableRecruitingLaval University302025-09-012026-06-05
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Tasimelteon Oral Suspension, Placebo - Insomnia Disorder
Phase 3RecruitingVanda Pharmaceuticals4202025-04-212026-06-05
Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic Insomnia
Cognitive Behavioral Treatment for Insomnia (CBT-I), Lemborexant, Placebo - Insomnia Disorder
Not applicableRecruitingLaval University902025-04-012025-04-09
Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder
YZJ-1139, Zolpidem - Insomnia Disorder
Phase 3CompletedShanghai Haiyan Pharmaceutical Technology Co., Ltd.612025-03-252026-06-29
Comparative Efficacy of BRT and CBT-I for Insomnia
Cognitive behavioral therapy for insomnia (CBT-I), Bedtime restriction (BRT) - Insomnia Disorders, Insomnia Disorder
Not applicableRecruitingChristoph Nissen1602025-03-102025-02-17
Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study
Cognitive Behavioral Therapy for Insomnia, Passive Body Heating (PBH) - Insomnia Disorder
Not applicableCompletedUniversity of California, San Francisco102025-02-072026-05-01
Digital CBT-I for Chronic Insomnia
digital CBT-I - Insomnia Chronic, Insomnia Disorder
Not applicableNot yet recruitingWELT corp1202025-01-012024-11-19
The Sleep Clinic Outcome and Practice Study
Chronotherapy, Cognitive Behavioral Therapy for Insomnia - Insomnia Disorder, Circadian Rhythm Sleep Disorder
Not applicableRecruitingSt. Olavs Hospital34002025-01-012026-07-20
A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder
Daridorexant, Placebo - Insomnia Disorder
Phase 3CompletedNxera Pharma Korea Co., Ltd.1642024-12-042026-01-21

Showing 20 of 69. Sign in to see all of them.

Narrower conditions

Sleep Initiation and Maintenance Disorders (69)  ·  Stress Disorders, Post-Traumatic (4)  ·  Psychological Well-Being (3)  ·  Sleep Wake Disorders (3)  ·  Anxiety Disorders (2)  ·  Depressive Disorder (2)  ·  Mood Disorders (2)  ·  Rumination Syndrome (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Alzheimer Disease (1)  ·  Brain Concussion (1)  ·  Chronic Pain (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)

Broader conditions

Dyssomnias (69)  ·  Mental Disorders (69)  ·  Nervous System Diseases (69)  ·  Sleep Disorders, Intrinsic (69)  ·  Sleep Wake Disorders (66)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (7)  ·  Trauma and Stressor Related Disorders (5)  ·  Behavior (4)  ·  Neurologic Manifestations (4)  ·  Stress Disorders, Traumatic (4)  ·  Mood Disorders (3)  ·  Personal Satisfaction (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)

Interventions

daridorexant (10)  ·  Cognitive Behavioral Therapy (6)  ·  Zolpidem (5)  ·  lemborexant (3)  ·  Autogenic Training (2)  ·  Cannabinol (1)  ·  Chronotherapy (1)  ·  Diphenhydramine (1)  ·  Doxepin (1)  ·  Educational Status (1)  ·  Estazolam (1)  ·  Flurazepam (1)  ·  Hypnotics and Sedatives (1)  ·  Inulin (1)  ·  Meditation (1)

Sponsors

Idorsia Pharmaceuticals Ltd. (8)  ·  VA Office of Research and Development (6)  ·  Laval University (5)  ·  Jiangsu Hansoh Pharmaceutical Co., Ltd. (3)  ·  Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (3)  ·  Eisai Inc. (2)  ·  University of California, San Francisco (2)  ·  University of Pennsylvania (2)  ·  AB Biotek (1)  ·  Ache Laboratorios Farmaceuticos S.A. (1)  ·  Big Health Inc. (1)  ·  Biolab Sanus Farmaceutica (1)  ·  Caitlin Cheruka (1)  ·  Christoph Nissen (1)  ·  Dongfang Hospital Beijing University of Chinese Medicine (1)

Countries

United States (26)  ·  Canada (11)  ·  China (10)  ·  Germany (10)  ·  Spain (6)  ·  Switzerland (6)  ·  France (5)  ·  South Korea (5)  ·  Poland (4)  ·  Sweden (4)  ·  Finland (3)  ·  Hungary (3)  ·  Italy (3)  ·  Australia (2)  ·  Belgium (2)

Top investigators

Ashley E Mason, PhD (2)  ·  Christi S. Ulmer, PhD (2)  ·  Shira Maguen, PhD (2)  ·  Adam R. Kinney, PhD OTR (1)  ·  Brendon Yee, MBChB, FRACP, FCCP, PhD (1)  ·  Camilla Hoyos, MPH, PhD (1)  ·  Charles M Morin, PhD (1)  ·  Charles Morin, PhD (1)  ·  Christoph Nissen, Prof.Dr. (1)

Results publications

PMID 37526060, PMID 37796657, PMID 35065036, PMID 36054921, PMID 37477771, PMID 38302765, PMID 38644625, PMID 41217192, PMID 23286463, PMID 26762403, PMID 31953863, PMID 32341187, PMID 32585700, PMID 33022048, PMID 33065820, PMID 33131027, PMID 33576735, PMID 33636648, PMID 34077032, PMID 34428360, PMID 34555554, PMID 35220140, PMID 35254948, PMID 35296912, PMID 35393934, PMID 35402894, PMID 36098936, PMID 36484969, PMID 36567058, PMID 37193566, PMID 37286927, PMID 37339396, PMID 37612115, PMID 38748321, PMID 39200725, PMID 39250131, PMID 39823487, PMID 40288253, PMID 40346496, PMID 40373353, PMID 40557879, PMID 40570832, PMID 40636932, PMID 40660750, PMID 41343796, PMID 41506007, PMID 41698831, PMID 41938624, PMID 42184726, PMID 42731804

NIH funding

R34AT012767 (2), 2015 (1), 2023 (1), I01HX002350 (1), P30AG021332 (1)